📈 Price History

Ratio Health

— Excellent

— Good

— Average

— Poor

By Category

📊 Sector Averages

About

Universal Technical Institute, Inc. provides transportation, skilled trades, and healthcare education programs in the United States.

Key Ratios Snapshot

📈 Growth Pattern

⚡ Latest Quarter —

See full financials →

📊 Quick Scorecard

Loading…

⭐ Superinvestors Holding UTI

View All Superinvestors →

Manager	Shares	Value	% of Fund	Period
Steve Cohen Point72 Asset Management	1.44M	$52.1M	0.07%	Mar 2026
Jim Simons Renaissance Technologies LLC	657.0K	$23.7M	0.04%	Mar 2026

SEC Form 13F data. 45-day lag from quarter end.

🔍 Concall Decoded

🎙 Management Tone Tracker Confident Specific → Stable 4 quarters analysed

Q3 2025

Confident Specific

Management uses phrases like 'strong performance', 'exceed expectations', 'confident in our ability to achieve and exceed targets', and provides specific numerical growth percentages (revenue +15%, net income +114%, adjusted EBITDA +37%). The tone is upbeat and assertive about regulatory tailwinds and execution.

Q4 2025

Confident Specific

Management repeatedly used phrases like 'exceeded such expectations', 'met or surpassed all raised guidance', and provided very specific numbers (e.g., revenue $836M, adjusted EBITDA $126.5M) and forward guidance with precise ranges. The tone was assured and data-driven throughout.

Q1 2026

Confident Specific

Management used precise figures (revenue $221M, baseline EBITDA $34.7M, new student starts 5,449) and repeatedly pointed to on-track execution and ahead-of-model campus performance, with no defensive or uncertain language.

Q2 2026 latest

Confident Specific

CEO states 'demand is strong, our model is working' and 'we have exceptionally clear visibility into the returns', reiterates that new campus San Antonio exceeded plan by nearly 60%, and CFO reaffirms all guidance metrics with specific ranges.

Guidance Reliability Pending · <3Q data

Investor Lens

The investment thesis is strengthened by this call. The company demonstrated better-than-expected execution on new campus ramps (San Antonio 60% above plan), strong demand across both divisions, and reaffirmed long-term targets of $1.2B revenue and ~$220M EBITDA by FY2029. The key change is higher confidence in organic growth repeatability, supported by a robust pipeline of new campuses and programs. However, near-term margin dilution from growth investments will persist through FY2027, with EBITDA dollar growth modest in FY2027 and more meaningful expansion in FY2028-2029. Next quarter, watch Q3 revenue growth (guided mid-to-high single-digit) and whether Q4 starts accelerate as expected, as well as any updates on B2B partnerships or Atlanta campus intake.

AI-generated concall tone analysis · Updated 2026-06-09 · Not investment advice

🎙 Management Tone Confident Specific → Stable 4 quarters Full tone analysis in Intelligence →

📊 MIXED Q2 revenue $221M, starts +14%, active students +7%, reaffirms FY26 guidance.

Revenue & Profitability

Q2 2026 revenue was $221.4M, up 6.7% year-over-year. Net income was $0.4M ($0.01 per diluted share). Baseline Adjusted EBITDA was $25.1M; reported Adjusted EBITDA (after $11M growth investments) was $14.1M. Full-year guidance reaffirmed: revenue $905-$915M, net income $40-$45M ($0.71-$0.80 EPS), baseline EBITDA >$150M, reported EBITDA $114-$119M.

Outlook

Management sees a structural shift in the labor market driven by AI, which is automating white-collar jobs and increasing demand for skilled trades and healthcare positions. They believe this trend is not cyclical but structural, underpinned by infrastructure needs for data centers, energy systems, and advanced manufacturing. The company reaffirmed its fiscal 2026 guidance, expecting high single-digit start growth in remaining quarters and a strong Q4.

Growth Drivers

Growth is driven by new campus openings (San Antonio, Atlanta, and three more in FY2026) and program expansions (20 new programs across both divisions in FY2026). The North Star strategy targets 2-5 new campuses and 12-20 new programs per year. Cross-brand collaboration between UTI and Concorde divisions, leveraging AI technology, aims to unlock incremental margin expansion.

Balance Sheet & CapEx

Year-to-date capital expenditures were $52.7M, approximately half of the expected total for fiscal 2026. The company plans for $100M or more in annual CapEx to support new campuses and programs. Growth investments in FY2026 total approximately $40M, with $11M incurred in Q2.

Margins

Margin contraction in Q2 was primarily due to growth investments and timing of marketing spend. Management expects margin improvement in Q3 and robust year-over-year EBITDA growth in Q4. For fiscal 2026, baseline EBITDA is expected to exceed $150M. Over the longer term, they target modest EBITDA dollar growth in FY2027 followed by more meaningful expansion in FY2028-2029 through operating leverage and efficiency.

Key Risks

Management highlighted the shift in consumer search behavior from traditional search to GenAI engines, which could impact student acquisition. They are addressing this by investing in AI-driven marketing and cross-divisional collaboration. No other explicit risks were flagged by management or analysts in the Q&A.

Generated by AI · Q2 2026 results · Not investment advice

✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter

🔍

🔎 See cross-company document search → ?

📞 Earnings Call Transcripts (5)

Q3 2026 Q3 2026 2026-08-05

Third quarter results showed strong revenue and enrollment growth, driven by skilled trades and new campuses, despite near-term softness in high school auto/diesel starts. Fiscal 2026 guidance was revised slightly lower, but long-term growth targets remain intact, supported by robust demand and ongoing program expansion.

Q2 2026 Q2 2026 2026-05-06

Q2 saw 7% revenue growth and 14% increase in new student starts, with both divisions contributing double-digit growth. Guidance for fiscal 2026 is reaffirmed, targeting 9% revenue growth and strong margin expansion, supported by robust demand, new campuses, and program launches.

Q1 2026 Q1 2026 2026-02-04

Q1 2026 saw 10% revenue growth and strong student metrics, with robust demand for new campuses and programs. Fiscal 2026 guidance and long-term targets were reiterated, supported by disciplined growth investments and a favorable regulatory environment.

Q4 2025 Q4 2025 2025-11-19

Revenue grew 14% to $835.6M in 2025, exceeding guidance, with strong student and program growth. Fiscal 2026 guidance projects 9% revenue growth, $114–$119M adjusted EBITDA, and major investments in new campuses and programs. Demand for skilled trades and healthcare remains robust.

Q3 2025 Q3 2025 2025-08-06

Q3 2025 saw revenue up 15% and net income up 114% year-over-year, with strong student growth and raised full-year guidance. Concorde's growth restrictions were lifted early, enabling accelerated expansion, while investments in new programs and campuses continue to drive momentum.

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯

Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.

📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.